e-learning
resources
London 2016
Monday, 05.09.2016
Severe respiratory infections in the intensive care unit and pleural and fungal infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment outcome in patients with chronic pulmonary aspergillosis by azole-resistant aspergillus fumigatus
keita Takeda (Tokyo, Japan), Keita Takeda, Junko Suzuki, Hideaki Nagai, Masahiro Kawashima, Nobuharu Ohsima, Atsuhisa Tamura, Shinobu Akagawa, Hirotoshi Matsui, Ken Ohta, Akira Watanabe, Katsuhiko Kamei
Source:
International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Session:
Severe respiratory infections in the intensive care unit and pleural and fungal infections
Session type:
Thematic Poster
Number:
2646
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
keita Takeda (Tokyo, Japan), Keita Takeda, Junko Suzuki, Hideaki Nagai, Masahiro Kawashima, Nobuharu Ohsima, Atsuhisa Tamura, Shinobu Akagawa, Hirotoshi Matsui, Ken Ohta, Akira Watanabe, Katsuhiko Kamei. Treatment outcome in patients with chronic pulmonary aspergillosis by azole-resistant aspergillus fumigatus. Eur Respir J 2016; 48: Suppl. 60, 2646
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Asbestosis
Related content which might interest you:
Our patients of candida and aspergillus pneumonia
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
Invasive pulmonary aspergillosis in immunosuppressed patients
Source: International Congress 2015 – How to approach and treat fungal and viral respiratory infections
Year: 2015
Invasive pulmonary disease in CGD patients by aspergillus
Source: Eur Respir J 2004; 24: Suppl. 48, 393s
Year: 2004
Cavitary formation in non-tuberculous mycobacterial infection is the significant risk for development to chronic pulmonary aspergillosis
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis
Source: Eur Respir J 2006; 28: 352-357
Year: 2006
Prolonged oral corticosteroid therapy in allergic bronchopulmonary aspergillosis (ABPA) treatment does not increase pseudomonas aeruginosa risk
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
Source: Eur Respir J 2011; 37: 865-872
Year: 2011
Clinical characteristics of pulmonary nocardiosis in immunocompetent patients
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015
Allergic bronchopulmonary aspergillosis and other fungal diseases
Source: Eur Respir Mon 2011; 52: 97-114
Year: 2011
Treatment of chronic pulmonary aspergillosis by voriconazole compared with micafungin
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Pulmonary infections in neutropenic patients
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003
Frequency of candida species mycoses isolation from patients with pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 422s
Year: 2004
Invasive pulmonary aspergillosis in patients with severe COPD. Compative study between probable invasive infection and colonization
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
Caspofungin to treat invasive pulmonary aspergillosis in sarcoidosis
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
Chronic pulmonary aspergillosis: Characteristics of 30 nonimmunocompromised patients
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011
Clinical characteristics and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept